CTRI/2026/02/102879尚未招募不适用
A Clinical Study to Evaluate the Efficacy and Safety of the Test Product in Adult Male and Female Participants with Mild to Moderate Eczema
Winnox Cosmeceutics (Wipro Consumer Care)1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2026年2月14日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
- 试验地点
- 1
研究概览
简要总结
This is an open label, non-randomized, single-arm interventional clinical study to evaluate the efficacy and safety of the test product in Adult Male and Female Participants with Mild to Moderate Eczema.
The potential participants will be screened as per the inclusion and exclusion criteria only after obtaining written informed consent from the participants.
All eligible participants will undergo clinical evaluation by a Dermatologist, instrument evaluation and subjective evaluation. Safety will be assessed throughout the study by monitoring adverse events.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •Participants diagnosed with Mild to Moderate Eczema (score between
- •based on Atopic Dermatitis Severity Index (ADSI) 2) Participants with itchy skin. 3) Participants with at least one prominent lesion. 4) Participants having good general health and free of any disease state or physical condition that might impair evaluation which in the Investigators opinion, exposes the participant to an unacceptable risk by study participation 5) Female participants of childbearing potential must have a negative urine pregnancy test at enrollment visit.
排除标准
- •Participants with serious skin conditions like psoriasis, Uraemic pruritus, etc.
- •Presence of any medical condition or disability that could interfere with study.
- •Participants with any clinically significant systemic disease.
- •Participants having known allergy to active ingredient/raw material of the test product.
- •Presence of any cutaneous condition on test site that could interfere with study.
研究者
Dr Bhagirath Patel
Cliantha Research
研究点 (1)
Loading locations...
相似试验
尚未招募
4 期
Tunlametinib + AG + Cetuximab β as First-Line Therapy for Advanced Pancreatic CancerNCT07302841Tianjin Medical University Cancer Institute and Hospital28
已完成
2/3 期
Clinical study on Vimosa Softgel in vaginal dryness and vaginal prolapseCTRI/2024/05/067423Abhinav Health Care Products Pvt Ltd72
尚未招募
不适用
A Study to Investigate the Safety and Effectiveness of the Technolas® TENEO 317 Model 2 Excimer Laser for Laser In Situ Keratomileusis (LASIK) Surgery to Treat Myopia or Myopic AstigmatismNCT07377474Bausch & Lomb Incorporated32
招募中
不适用
A Study to Evaluate How Effectively Amrutveni LiceQit Oil Treats Head Lice Infestation in Children and Adults.CTRI/2025/10/096413Sahyadri Bio Labs Pvt. Ltd36
尚未招募
不适用
A study to evaluate the efficacy of test regime in adult males with male pattern baldness.CTRI/2025/07/091602Anveya Living Private Limited50